Research / ESCA / Fundamental state Inspectable configuration
State dimensions Filing 0001437749-25-006863 General Corporate
Debt relative to revenue 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
10.18% · OPTIONAL · VALID
Capex intensity 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.81% · OPTIONAL · VALID
Operating cash generation 80th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
14.33% · OPTIONAL · VALID
Revenue growth 40th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-4.57% · CORE · VALID
Inventory pressure 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
30.23% · OPTIONAL · VALID
Operating margin 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
7.95% · CORE · VALID
R&D intensity 100th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.27% · OPTIONAL · VALID
SBC intensity 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.77% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 46 states Self-history eligible
Mar 19, 2022 7/7 normalized Level 3 Jul 9, 2022 7/7 normalized Level 3 Oct 1, 2022 7/7 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Amended as filed Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2022 8/8 normalized Amended as filed Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 6/6 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 43.54%
Current 10.18%
Delta -33.37% Capex Intensity Increased
Previous 0.45%
Current 0.81%
Delta 0.36% Cash Generation Decreased
Previous 15.44%
Current 14.33%
Delta -1.11% Growth Increased
Previous -7.66%
Current -4.57%
Delta 3.09% Inventory Pressure Decreased
Previous 126.20%
Current 30.23%
Delta -95.97% Profitability Decreased
Previous 11.77%
Current 7.95%
Delta -3.82% Sbc Intensity Increased
Previous 0.74%
Current 0.77%
Delta 0.03% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.